Revolutionizing Drug Discovery: ABB's Robotics Ecosystem

The DAWN of a New Era in Life Sciences

The life sciences sector is poised on the cusp of a revolutionary revolution. Spurred by technological innovation and an ever-spiraling requirement for faster, more precise drug discovery, labs are rapidly embracing automation. ABB, the leading industrial automation player, is at the forefront of this exciting transition. Through strategic partnerships and groundbreaking robotics technology, ABB is facilitating researchers to accelerate research, unlock new possibilities, and deliver life-saving treatments to market more rapidly.

Overcoming the Challenges of Contemporary Drug Discovery

The contemporary drug discovery environment is characterized by a myriad of challenges. Increasing costs, complex research processes, and an ongoing lack of skilled personnel are major obstacles. In addition, the capacity to effectively analyze large amounts of data is vital in order to identify potential drug candidates and optimize testing protocols.

ABB recognizes these challenges and is striving hard to develop innovative solutions. "We collaborate across industries like pharmaceuticals, biotechnology, and healthcare to deliver automation solutions that enhance data integrity, efficiency, and process quality," states Jose-Manuel Collados, Product Line Service Robotics Manager at ABB.

The Power of Collaboration

ABB's success relies on its collaborative approach. Through strategic alliances with industry leaders like Mettler Toledo and Agilent Technologies, ABB is establishing a robust ecosystem of lab automation. This collaborative approach streamlines automation processes, ensuring the delivery of trusted, fully validated products backed by in-depth global service.

The Rise of Collaborative Robots

The foundation of ABB's automation solutions is the GoFa™ collaborative robot. The cutting-edge technology is revolutionizing lab operations. "GoFa offers leading class speed, safety, and ease of use, making it an ideal solution for tasks like powder dispensing, pipetting, and beyond," explains Collados.

GoFa's collaborative approach is revolutionary. Designed to augment human operators with ease, it automates mundane tasks so scientists can focus on more worthy tasks like analysis and interpretation of data. The collaborative model not only boosts productivity but also makes it possible to capture useful process knowledge so that dynamic adjustments and ongoing improvement are feasible.

Precision and Reliability: Pillars of Success

In the delicate context of drug discovery, precision and reliability are paramount. Robotics technology from ABB plays a significant role in minimizing sample variation and eliminating human error, thus enhancing analytical method accuracy and reliability.

"Automating sample preparation with ABB robot technology minimizes sample variability and reduces human error, greatly improving the accuracy and reliability of subsequent analytical processes, including high-performance liquid chromatography (HPLC)," Collados says.

The Future of Lab Automation: A Vision of 'Lights Off'

The use of collaborative robots is paving the way for a future where labs can operate on their own for extended periods of time. "New technological innovations in the field of cobot models, autonomous mobile robots, and artificial intelligence will facilitate drug discovery and development. But the fact is that technology is being developed in collaboration with scientific and process experts," emphasizes Collados. This collaborative approach ensures that the technology not only caters to the needs of the scientific community but also results in major breakthroughs in global healthcare.

Recommended ABB Products